Amy S. Chappell

4.4k total citations
52 papers, 2.7k citations indexed

About

Amy S. Chappell is a scholar working on Pharmacology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Amy S. Chappell has authored 52 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 21 papers in Physiology and 21 papers in Psychiatry and Mental health. Recurrent topics in Amy S. Chappell's work include Musculoskeletal pain and rehabilitation (20 papers), Pain Mechanisms and Treatments (19 papers) and Pain Management and Placebo Effect (17 papers). Amy S. Chappell is often cited by papers focused on Musculoskeletal pain and rehabilitation (20 papers), Pain Mechanisms and Treatments (19 papers) and Pain Management and Placebo Effect (17 papers). Amy S. Chappell collaborates with scholars based in United States, United Kingdom and Germany. Amy S. Chappell's co-authors include Vladimir Skljarevski, Hong Liu‐Seifert, Michael J. Detke, Daniel K. Kajdasz, Daniel Walker, Philip J. Mease, Madelaine M. Wohlreich, Smriti Iyengar, Yili Pritchett and D. Desaiah and has published in prestigious journals such as Neurology, Diabetes Care and Pain.

In The Last Decade

Amy S. Chappell

50 papers receiving 2.6k citations

Peers

Amy S. Chappell
Deborah N. D’Souza United States
Vladimir Skljarevski United States
Yili Lu United States
Marc Kamin United States
Hong Liu‐Seifert United States
Uma Sharma United States
Ahmad Beydoun United States
José Manuel Castro‐Lopes Portugal
Rae Frances Bell Norway
Mugdha Gore United States
Deborah N. D’Souza United States
Amy S. Chappell
Citations per year, relative to Amy S. Chappell Amy S. Chappell (= 1×) peers Deborah N. D’Souza

Countries citing papers authored by Amy S. Chappell

Since Specialization
Citations

This map shows the geographic impact of Amy S. Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy S. Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy S. Chappell more than expected).

Fields of papers citing papers by Amy S. Chappell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy S. Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy S. Chappell. The network helps show where Amy S. Chappell may publish in the future.

Co-authorship network of co-authors of Amy S. Chappell

This figure shows the co-authorship network connecting the top 25 collaborators of Amy S. Chappell. A scholar is included among the top collaborators of Amy S. Chappell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy S. Chappell. Amy S. Chappell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Arnerić, Stephen P., Jennifer M.A. Laird, Amy S. Chappell, & Jeffrey D. Kennedy. (2013). Tailoring chronic pain treatments for the elderly: are we prepared for the challenge?. Drug Discovery Today. 19(1). 8–17. 12 indexed citations
4.
Bennett, Robert M., I. Jon Russell, Ernest Choy, et al.. (2012). Evaluation of Patient-Rated Stiffness Associated With Fibromyalgia: A Post-Hoc Analysis of 4 Pooled, Randomized Clinical Trials of Duloxetine. Clinical Therapeutics. 34(4). 824–837. 20 indexed citations
5.
Skljarevski, Vladimir, Shuyu Zhang, Smriti Iyengar, et al.. (2011). Efficacy of Duloxetine in Patients with Chronic Pain Conditions. Current Drug Therapy. 6(4). 296–303. 36 indexed citations
6.
Bradley, Laurence A., Robert M. Bennett, I. Jon Russell, et al.. (2010). Effect of duloxetine in patients with fibromyalgia: tiredness subgroups. Arthritis Research & Therapy. 12(4). R141–R141. 4 indexed citations
7.
Chappell, Amy S., D. Desaiah, Hong Liu‐Seifert, et al.. (2010). A Double‐blind, Randomized, Placebo‐controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee. Pain Practice. 11(1). 33–41. 172 indexed citations
8.
Arnold, Lesley M., James I. Hudson, Fujun Wang, et al.. (2009). Comparisons of the Efficacy and Safety of Duloxetine for the Treatment of Fibromyalgia in Patients With Versus Without Major Depressive Disorder. Clinical Journal of Pain. 25(6). 461–468. 21 indexed citations
9.
Skljarevski, Vladimir, D. Desaiah, Qi Zhang, et al.. (2009). Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain. Diabetes/Metabolism Research and Reviews. 25(7). 623–631. 28 indexed citations
10.
Pascuzzi, Robert M., Jeremy M. Shefner, Amy S. Chappell, et al.. (2009). A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis. 11(3). 266–271. 100 indexed citations
11.
Farrar, John T., Yili Pritchett, Michael J. Robinson, Apurva Prakash, & Amy S. Chappell. (2009). The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders. Journal of Pain. 11(2). 109–118. 205 indexed citations
12.
Arnold, Lesley M., Daniel J. Clauw, Madelaine M. Wohlreich, et al.. (2009). Efficacy of Duloxetine in Patients With Fibromyalgia. The Primary Care Companion to The Journal of Clinical Psychiatry. 11(5). 237–244. 72 indexed citations
13.
Hunter, Aimee M., Andrew F. Leuchter, Ian A. Cook, et al.. (2009). Brain Functional Changes and Duloxetine Treatment Response in Fibromyalgia: A Pilot Study. Pain Medicine. 10(4). 730–738. 17 indexed citations
14.
Chappell, Amy S., G. Littlejohn, Daniel K. Kajdasz, et al.. (2009). A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia. Clinical Journal of Pain. 25(5). 365–375. 53 indexed citations
15.
Fishbain, David A., Michael J. Detke, Joachim Wernicke, Amy S. Chappell, & Daniel K. Kajdasz. (2008). The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder. Current Medical Research and Opinion. 24(11). 3105–3115. 24 indexed citations
16.
17.
Wernicke, Joachim, Fujun Wang, Yili Pritchett, et al.. (2007). An Open-Label 52-Week Clinical Extension Comparing Duloxetine with Routine Care in Patients with Diabetic Peripheral Neuropathic Pain. Pain Medicine. 8(6). 503–513. 39 indexed citations
18.
Jhee, S. S., Amy S. Chappell, Victoria Zarotsky, et al.. (2006). Multiple‐Dose Plasma Pharmacokinetic and Safety Study of LY450108 and LY451395 (AMPA Receptor Potentiators) and Their Concentration in Cerebrospinal Fluid in Healthy Human Subjects. The Journal of Clinical Pharmacology. 46(4). 424–432. 26 indexed citations
19.
Chappell, Amy S.. (2001). Pearls and Pitfalls of Clinical Trial Investigation: Should I Get Involved in the Drug Development Process?. Seminars in Neurology. 21(4). 417–424. 1 indexed citations
20.
Sang, Christine N., Richard H. Gracely, Amy S. Chappell, et al.. (1998). AMPA/Kainate Antagonist LY293558 Reduces Capsaicin-evoked Hyperalgesia but Not Pain in Normal Skin in Humans . Anesthesiology. 89(5). 1060–1067. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah N. D’Souza Breakdown of academic impact, for papers by Vladimir Skljarevski Breakdown of academic impact, for papers by Yili Lu Breakdown of academic impact, for papers by Marc Kamin Breakdown of academic impact, for papers by Hong Liu‐Seifert Breakdown of academic impact, for papers by Uma Sharma Breakdown of academic impact, for papers by Ahmad Beydoun Breakdown of academic impact, for papers by José Manuel Castro‐Lopes Breakdown of academic impact, for papers by Rae Frances Bell Breakdown of academic impact, for papers by Mugdha Gore
Rankless by CCL
2026